US 10,137,224 B2
Allogeneic microvascular tissue for soft tissue treatments
Dale R. Peterson, Carlsbad, CA (US); and Richard B. Emmitt, Oldwick, NJ (US)
Assigned to MICROVASCULAR TISSUES, INC., San Diego, CA (US)
Filed by MicroVascular Tissues, Inc., Beverly, MA (US)
Filed on Apr. 28, 2015, as Appl. No. 14/698,763.
Application 14/698,763 is a continuation of application No. 13/423,171, filed on Mar. 17, 2012, granted, now 9,044,430.
Claims priority of provisional application 61/454,367, filed on Mar. 18, 2011.
Prior Publication US 2016/0015859 A1, Jan. 21, 2016
This patent is subject to a terminal disclaimer.
Int. Cl. A61L 27/36 (2006.01); A61K 35/12 (2015.01); A61K 35/35 (2015.01); C12N 5/077 (2010.01); A61K 35/28 (2015.01); A61L 27/54 (2006.01); A61L 27/56 (2006.01); A61L 27/38 (2006.01)
CPC A61L 27/3662 (2013.01) [A61K 35/12 (2013.01); A61K 35/28 (2013.01); A61K 35/35 (2013.01); A61L 27/3604 (2013.01); A61L 27/3625 (2013.01); A61L 27/3683 (2013.01); A61L 27/3687 (2013.01); A61L 27/3691 (2013.01); A61L 27/3834 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); C12N 5/0653 (2013.01); A61L 2300/64 (2013.01); A61L 2430/06 (2013.01); A61L 2430/10 (2013.01)] 25 Claims
 
1. A processed microvascular tissue comprising:
a dried microvascular tissue, wherein the microvascular tissue comprises dissociated, and uncultured stem or progenitor cells having intact cell membranes, wherein the viability of the uncultured stem or progenitor cells in the processed microvascular tissue is less than 30%, and wherein the processed microvascular tissue has tissue healing activity.